Human medicines European public assessment report (EPAR): Hizentra, human normal immunoglobulin (SCIg), Date of authorisation: 14/04/2011, Revision: 25, Status: Authorised

ICH guideline E11A on pediatric extrapolation - Scientific guideline

ICH guideline E11A on pediatric extrapolation Step 5

Human medicines European public assessment report (EPAR): Carmustine medac (previously Carmustine Obvius), carmustine, Date of authorisation: 18/07/2018, Revision: 11, Status: Authorised

Human medicines European public assessment report (EPAR): Jevtana, cabazitaxel, Date of authorisation: 17/03/2011, Revision: 24, Status: Authorised

Concept paper on revision of the Guideline on Risk Assessment of Medicinal Products on Human Reproduction and Lactation: from Data to Labelling

Human medicines European public assessment report (EPAR): Pramipexole Teva, pramipexole, Date of authorisation: 18/12/2008, Revision: 24, Status: Authorised

Ozempic / Victoza

Paediatric Committee (PDCO): 3-6 September 2024, European Medicines Agency, Amsterdam, the Netherlands, from 3 September 2024 to 6 September 2024

Agenda - PDCO agenda of the 3-6 September 2024 meeting